Overview
Netherlands chemicals distributor's full-year revenue rose 5% on constant currency basis
Operating EBITA slightly missed analyst expectations
Company completed 7 acquisitions in 2025
Outlook
Company cites macroeconomic conditions and geopolitical unrest as challenges for future growth
Result Drivers
SOFTER DEMAND - CEO Marcus Jordan noted softer demand across regions and markets, stalling organic growth
ACQUISITIONS - IMCD completed 7 strategic acquisitions in 2025 to enhance customer and supplier offerings
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
FY EBITA
Slight Miss*
EUR 498 mln
EUR 500.58 mln (10 Analysts)
FY Free Cash Flow
EUR 465 mln
FY Gross Profit
EUR 1.19 bln
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for IMCD NV is €116.50, about 31.1% above its February 17 closing price of €88.86
The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 15 three months ago
Press Release: ID:nGNE3DJnpz
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
